Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment Update in Multiple Sclerosis.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
The prevalence of multiple sclerosis in the city of Santos has remained unaltered for five years.
Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
Identifying and treating pain caused by MS.
Persistence of Epstein-Barr Virus in Self-reactive Memory B Cells.
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
The role of mast cells in neuroinflammation.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Diet, microbiota and autoimmune diseases.
Co-Existence of Familial Mediterranean Fever and Multiple Sclerosis in Two Patients.
Our products
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
'Green Mice' display limitations in enhanced green fluorescent protein expression in retina and optic nerve cells.
Multiple sclerosis: managing a complex neurological disease.
Imaging Phenotypes in Multiple Sclerosis.
Preliminary Investigation of Gait Initiation and Falls in Multiple Sclerosis.
Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
Differential Diagnosis of White Matter Lesions: Nonvascular Causes-Part II.
The role of microglial activation in disease progression.
Pages
« first
‹ previous
…
275
276
277
278
279
280
281
282
283
…
next ›
last »